Al-'Aqar Healthcare REIT Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Al-'Aqar Healthcare REIT stock has a consensus rating of "Buy" and an average price target of RM 1.35. The average 1-year stock price forecast is 15.38% higher than the current stock price, while the lowest is RM 1.30 (+11.11%) and the highest is RM 1.40 (+19.66%).

Price Target: RM 1.35 (+15.38%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	RM 1.30	RM 1.35	RM 1.35	RM 1.40
Change	+11.11%	+15.38%	+15.38%	+19.66%

Analyst Ratings

The average analyst rating for Al-'Aqar Healthcare REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	May '25	Aug '25	Nov '25	Dec '25	Feb '26	May '26
Strong Buy	0	0	0	0	0	1
Buy	0	0	0	0	0	0
Hold	1	1	2	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	2	2	2	2

Financial Forecast

Revenue This Year

120.00M

from 120.34M

-0.28%

from 120.34M

Revenue Next Year

129.15M

from 120.00M

7.63%

from 120.00M

EPS This Year

0.07

from 0.07

12.80%

from 0.07

EPS Next Year

0.08

from 0.07

10.48%

from 0.07

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	115.23M	112.17M	123.20M	104.17M	120.34M	120.00M
Revenue Growth	-2.46%	-2.66%	9.84%	-15.45%	15.53%	-0.28%
Net Income	73.55M	60.14M	60.69M	58.27M	55.72M	66.00M
EPS	-	-	-	-	0.07	0.07
EPS Growth	-	-	-	-	-4.32%	12.80%
Forward PE	-	-	-	-	-	15.62
Dividend / Share	0.08	0.08	0.08	0.07	0.07	0.07
Dividend Growth	-	3.85%	-2.47%	-7.97%	-2.89%	1.98%
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is MYR.

Revenue Forecast

Revenue	2026	2027
High	120.0M
Avg	120.0M
Low	120.0M

Revenue Growth

Revenue Growth	2026	2027
High	-0.3%
Avg	-0.3%
Low	-0.3%

EPS Forecast

EPS	2026	2027
High	-
Avg	0.07
Low	-

EPS Growth

EPS Growth	2026	2027
High	-
Avg	12.8%
Low	-